Is the pendulum slowly starting to swing back?
- PMID: 40016844
- PMCID: PMC11866555
- DOI: 10.1186/s40959-025-00321-w
Is the pendulum slowly starting to swing back?
Keywords: Cardiac monitoring guidelines; Cardio-oncology; False-positive cardiac ultrasound adjudications; Trastuzumab; Type II cardiotoxicity.
Conflict of interest statement
Declarations. Competing interests: The authors have no competing interests.
References
-
- Slamon DJ, Leyland-Jones B, Shak S, Fuchs H, Paton V, Bajamonde A, Fleming T, Eiermann W, Wolter J, Pegram M, Baselga J, Norton L. Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. N Engl J Med. 2001;344(11):783 − 92. 10.1056/NEJM200103153441101. PMID: 11,248,153.Bottom of Form. - PubMed
-
- Feldman AM, Lorell BH, Reis SE. Trastuzumab in the treatment of metastatic breast cancer: anticancer therapy versus cardiotoxicity. Circulation. 2000;102(3):272-4. 10.1161/01.cir.102.3.272. PMID: 10,899,087. - PubMed
-
- Ewer MS, Gibbs HR, Swafford J, Benjamin RS. Cardiotoxicity in patients receiving trastuzumab (Herceptin): primary toxicity, synergistic or sequential stress, or surveillance artifact? Semin Oncol. 1999;26(4 Suppl 12):96–101. PMID: 10,482,200. - PubMed
-
- Ewer MS, Ewer SM. Cardiotoxicity of anticancer treatments. Nat Rev Cardiol. 2015;12(9):547 − 58. 10.1038/nrcardio.2015.65. Epub 2015 May 12. Erratum in: Nat Rev Cardiol. 2015 Nov;12(11):620. 10.1038/nrcardio.2015.133. PMID: 25,962,976. - PubMed
-
- Ewer MS, Lippman SM. Type II chemotherapy-related cardiac dysfunction: time to recognize a new entity. J Clin Oncol. 2005;23(13):2900-2. 10.1200/JCO.2005.05.827. PMID: 15,860,848. - PubMed
Publication types
LinkOut - more resources
Full Text Sources